Here are five key notes:
1. National Bank Financial issued the updated target price Nov. 10.
2. The brokerage firm has a “sector perform” rating on MFC shares.
3. In November, Royal Ban of Canada lowered MFC’s target price from $14 to $13.
4. MFC shares opened Nov. 25 trading at $13.40.
5. The company’s 12-month low is $11.14 and 12-month high is $19.90.
More articles on transactions/valuations:
Kernersville Endoscopy Center proposes new ASC
Hartford HealthCare, Constitution Surgery open new ASC — 4 insights
AtlantiCare Health Park obtains regulatory approval for building with surgery center: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
